The Journal of Infectious Diseases · 1980 · 51 citations · 13 references
PharmacyInfectious DiseasesPharmacotherapyInfectious Disease PharmacotherapyPharmacovigilanceVirologyAntiviral PharmacologyAntiviral TherapyRespiratory Infection ControlAntiviral Safety AssessmentControlled Field TrialsField Trial EvaluationInfluenza Antiviral TherapyInfluenza Infection ControlInfluenza TreatmentYoung Adulthood
The usefulness of amantadine in the protection of humans against influenza A (H1N1) virus was evaluated in a double-blind field trial with 555 volunteers in Finland in the winter of 1978. Three populations--patients in a general hospital, adults in a home for the aged, and two groups of military conscripts--were chosen. Epidemic influenza occurred only in the two groups of conscripts: the incidence of serologically verified influenza was 66% and 83% in the groups that received placebo and 43% and 51% in the groups that received amantadine, giving protection rates of 36% (P = 0.05) and 39% (P = 0.001). The evaluation of the effect of amantadine on the occurrence of illness was obscured by concomitant adenoviral infections that caused influenza-like symptoms. No clear difference in the occurrences of side effects was observed between the placebo and amantadine-treated groups; however, a significantly greater number of participants who took 200 mg of amantadine/day (16.9%) stopped medication during the trial as compared with the placebo groups (7.6%) (P < 0.02).
13
Prevention of Russian Influenza by Amantadine
Arnold S. Monto · JAMA · 1979 · 121 citations
Studies on Induced Influenza in Man
Yasushi Togo · JAMA · 1968 · 115 citations